Giuseppe Matarese

Naples, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 201 publications

Corrigendum to "Physical exercise modulates T cell activity and mitigates synaptic dysfunction in multiple sclerosis through vagus nerve engagement" [Brain, Behav., Immun. 135 (2026) 106523, ISSN 0889-1591].

Corrigendum to "Physical exercise modulates T cell activity and mitigates synaptic dysfunction in multiple sclerosis through vagus nerve engagement" [Brain, Behav., Immun. 135 (2026) 106523, ISSN 0889-1591].

Journal: Brain, behavior, and immunity

Published: August 12, 2026

FCGR3A Polymorphism Controls B-Cell Repopulation Kinetics in People With Multiple Sclerosis Treated With Ocrelizumab.

FCGR3A Polymorphism Controls B-Cell Repopulation Kinetics in People With Multiple Sclerosis Treated With Ocrelizumab.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: August 11, 2026

SREBP1c modulates Treg immunobiology through a phospholipid-dependent adenosine pathway.

SREBP1c modulates Treg immunobiology through a phospholipid-dependent adenosine pathway.

Journal: The Journal of clinical investigation

Published: July 21, 2026

CCL2: A Pro-Inflammatory Driver and Candidate Diagnostic Biomarker in Colorectal Cancer Patients.

CCL2: A Pro-Inflammatory Driver and Candidate Diagnostic Biomarker in Colorectal Cancer Patients.

Journal: International journal of molecular sciences

Published: May 26, 2026

IL-6 trans-signalling in cancer metabolism, multidrug resistance and chronic inflammation.

IL-6 trans-signalling in cancer metabolism, multidrug resistance and chronic inflammation.

Journal: The Journal of biological chemistry

Published: March 21, 2026

Effect of dynamics and timing of SARS-CoV-2 vaccination on immune response in people with multiple sclerosis during cladribine treatment.

Effect of dynamics and timing of SARS-CoV-2 vaccination on immune response in people with multiple sclerosis during cladribine treatment.

Journal: Clinical immunology (Orlando, Fla.)

Published: December 29, 2025

Immunophenotypic skewing of B cells toward IgD⁻CD27⁻IgG⁺ subtype and metabolic attenuation in colorectal cancer.

Immunophenotypic skewing of B cells toward IgD⁻CD27⁻IgG⁺ subtype and metabolic attenuation in colorectal cancer.

Journal: Scientific reports

Published: December 17, 2025

Treg Susceptibility to Cladribine-Induced Depletion Correlates With Therapy Response in Patients With Multiple Sclerosis.

Treg Susceptibility to Cladribine-Induced Depletion Correlates With Therapy Response in Patients With Multiple Sclerosis.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: December 17, 2025

The immunoregulatory role of progesterone during embryo implantation and pregnancy.

The immunoregulatory role of progesterone during embryo implantation and pregnancy.

Journal: Trends in endocrinology and metabolism: TEM

Published: November 17, 2025

Multiple sclerosis-associated EBNA2 variants influence the response to peginterferon beta-1a therapy.

Multiple sclerosis-associated EBNA2 variants influence the response to peginterferon beta-1a therapy.

Journal: Journal of autoimmunity

Published: November 07, 2025

SREBP1c modulates Treg immunobiology through a phospholipid-dependent adenosine pathway.

SREBP1c modulates Treg immunobiology through a phospholipid-dependent adenosine pathway.

Journal: The Journal of clinical investigation

Published: October 15, 2025

Thyroid hormone activation drives fibroblast identity and tumor remodeling in cutaneous squamous cell carcinoma.

Thyroid hormone activation drives fibroblast identity and tumor remodeling in cutaneous squamous cell carcinoma.

Journal: Cell reports

Published: September 24, 2025

Showing 1-12 of 201

Last Updated: 09/26/2026